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23.1  Stratum Corneum and 
Chemical Xenobiotics 
 The interaction between surfactants and the stra-
tum corneum (SC) has many-sided aspects. Lipid 
removal, protein denaturation, corneocyte swell-
ing, impaired SC barrier function, and SC rough-
ness induction are among the best recognized 
effects. Testing skin compatibility of surface- 
active agents usually relies on a large panel of 
volunteers. Such a procedure is costly and time 
consuming. As a result, several alternative meth-
ods were designed both in vivo and in vitro. 
 Skin washing with a cleanser is occasion-
ally responsible for both sensorial and chemical 
irritations. Most individuals complaining with 
sensorial or chemical irritation fi nd it necessary 
to select skin cleansers using a trial-and-error 
approach. However, a number of in vivo methods 
and in vitro tests were described for the prediction 
of potential surfactant irritancy. These include 
the so-called pH rise of bovine serum albumin, 
the corneocyte swelling, the collagen swelling, 
and the zein solubilization tests [ 1 ]. Under some 
experimental conditions, however, data gained 
by these regular tests failed to  correlate with in 
vivo observations [ 2 ]. Such pitfalls suggested 
that other relevant in vitro methods would be 
welcome. 
23.2  Corneosurfametry 
 The interaction between the SC and various 
chemical xenobiotics is conveniently assessed on 
cyanoacrylate skin surface strippings (CSSS). 
Corneosurfametry (CSM) was coined after cor-
neocyte, surfactant, and metry. It refers to effects 
of surfactants and wash solutions on the SC 
[ 3 – 8 ]. For this purpose, CSSS are harvested from 
the inner forearms of healthy volunteers. A solu-
tion of the test product or its neat formulation is 
sprayed over a series of CSSS which are placed 
in plastic trays covered by lids. After a given 
period of incubation at controlled temperature, 
the samples are thoroughly but gently rinsed in 
running tap water, air-dried, and stained for 3 min 
in a toluidine blue-basic fuchsin solution. 
Thereafter, the samples are copiously rinsed with 
water and dried prior to perform color 
 quantifi cation using refl ectance colorimetry. 
Indeed, surfactants remove lipids and denaturate 
corneocyte proteins, thus disclosing chemical 
sites available for staining reactivity. A combined 
dotted and rimmed pattern is visible on corneo-
cytes at the microscopic examination. 
 Using quantitative refl ectance colorimetry 
(Chroma Meter CR400, Minolta, Osaka, Japan), 
the mean values of luminancy ( L *) and Chroma 
 C * are calculated from measurements made on 
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three sites from each sample placed on a white 
reference tile. Mild surfactants exhibiting little 
denaturating effect on corneocytes give a combi-
nation of high  L * values and low Chroma  C * val-
ues. Typically,  L * decreases and Chroma  C * 
increases with the irritancy potential of the prod-
uct. The difference between the  L * and Chroma 
 C * values of each sample represents the colori-
metric index of mildness (CIM). The CSM index 
(CSMI) of a given test product corresponds to the 
difference in color between water-treated control 
samples and those samples exposed to the test 
product. It is conveniently calculated according 
to the following formula: 
 CSMI L 2 C 2 5= +Δ Δ* * .0   
 Increasing the temperature at which CSM is 
run increases the SC reactivity [ 9 ]. The micro-
wave CSM variant is a more rapid procedure 
[ 10 ]. In this procedure, CSSS are immersed in 
a fl ask containing the test surfactant solution. 
Samples are then placed in a microwave oven 
containing a 500-ml water load. Microwave CSM 
is  conveniently run at 750 W for 30 s. The next 
steps are identical to the regular CSM procedure. 
 Responsive CSM is a variant method where 
skin has been preconditioned before CSSS 
 sampling [ 11 ]. For instance, the method is based 
on repeat subclinical injuries by surfactants 
monitored in a controlled forearm immersion 
test. At completion of the preliminary in vivo 
 preconditioning procedure, CSSS are harvested 
for a regular or microwave CSM bioassay using 
the same surfactant as in the preconditioning in 
vivo procedure. Preconditioning the skin by this 
way increases CSM sensitivity helping to dis-
criminate among mild surfactants [ 11 ]. In this 
context, subjects with atopic dermatitis com-
monly show increased CSM reactivity [ 12 ]. 
Similarly, some individuals with sensorial irrita-
tion exhibit increased CSM reactivity [ 13 ]. 
 Shielded CSM was designed for testing the 
so-called skin protection products [ 14 ]. Such 
products claiming for a barrier effect should the-
oretically shield against noxious agents. In 
shielded CSM, regular CSSS are fi rst covered by 
the test skin protection product ahead from 
 performing CSM using a reference surfactant. 
Comparative screenings of skin protection 
 products are conveniently performed using 
shielded CSM without exposing volunteers to 
any potential hazards linked to in vivo testing. 
 Animal CSM can be performed in a way  similar 
to human CSM [ 15 ]. The method is available for 
safety testing of cleansing products specifi cally 
designed for some animal species. In addition, 
any interspecies differences in skin reactivity to 
surfactants are conveniently assessed [ 15 ]. 
23.3  Corneoxenometry 
 The corneoxenometry (CXM) bioassay was 
named after corneocyte, xenobiotic, and metry. 
It was introduced as a convenient approach to 
explore the effect of some chemical xenobiotics 
other than surfactants on human SC [ 16 ,  17 ]. The 
basic procedure is similar to CSM and its vari-
ants. The main CXM indication resides in testing 
skin irritation while avoiding any in vivo haz-
ards. Another indication concerns the compara-
tive assessment of penetration enhancers 
commonly used in topical formulations [ 18 ]. Still 
another CXM indication deals with the determi-
nation of a dose-effect relationship for agents 
active on the SC structure and function [ 19 ]. 
 CXM was used for testing a series of chemi-
cals harmful to the SC [ 16 – 20 ]. The bioassay 
entails collection of CSSS from normal human 
skin. The harvested SC sheet, uniform in thick-
ness, is subjected to the ex vivo action of the 
selected xenobiotics. Series of CSSS covered in 
excess by their respective chemicals are kept for 
2 h at room temperature in a closed environment, 
for instance an oven, to prevent evaporation of 
the test solution. Samples are then thoroughly 
rinsed under running tap water, air-dried, and 
stained with a toluidine blue-basic fuchsin solu-
tion at pH 3.45 for 3 min. Any lipid removal and 
protein denaturation induce increased dye bind-
ing on corneocytes. It has been shown that harsh 
compounds to the skin considerably increase the 
intensity of staining of the CSSS [ 1 ,  4 ,  11 ,  13 , 
 16 ,  17 ,  20 ,  21 ]. After placing the samples on a 
white reference tile, refl ectance colorimetry 
(Chroma Meter CR400 Minolta) is used to derive 
the  L * and Chroma  C * values. Colorimetric 
data objectively quantify the CXM bioassay. 
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The colorimetric index of mildness (CIM) is 
calculated as previously defi ned [ 11 ,  16 ,  17 , 
 20 ,  21 ] following CIM =  L * − Chroma  C *. The 
relative irritancy index (RII) is calculated fol-
lowing [RII = 1 − [(CIM product) (CIM water) −1 ]. 
Obviously, RII is not a direct measure of the bar-
rier function. However, it correlates with clinical 
signs of irritancy. In fact the bioassay explores 
the combined effects of lipid removal and disor-
ganization and of protein denaturation as well. 
Hence, any rise in RII is a clue for SC damage 
responsible for barrier function impairment. 
23.4  Penetration Enhancer 
Testing 
 One of the upmost important functions of the 
epidermis is the formation of a well-structured 
barrier between the body and the ingress of poten-
tially noxious xenobiotics. The latter compounds 
correspond to environmental contaminants, 
chemical irritants, toxins, and still others. The 
barrier function is vital to keep constant the inter-
nal living tissues. Much research was performed 
to understand the skin barrier function of the SC. 
In some instances, however, chemical penetration 
enhancers (absorption enhancers or accelerants) 
represent an attractive potential overcoming the 
barrier effi cacy and increasing drug penetration 
through the SC. Penetration enhancers typically 
induce a temporary and reversible decrease in 
the skin barrier properties. They act in a number 
of ways, some of which altering the solubility 
properties or disrupting the ordered nature of the 
epidermal lipids [ 22 ]. Other molecules alter the 
intercorneocyte cohesiveness. 
 The desirable attributes for penetration 
enhancers are varied [ 22 – 24 ]. The compound 
should be pharmacologically inert without any 
effect at receptor biologic sites. The risk for irri-
tation, allergy, and toxicity should be minimal. 
The enhancer should be compatible, both chemi-
cally and physically, with drugs and vehicles in 
the dosage form. It should possess a rapid onset 
of action with a predictable duration of activity. 
In addition, the effects should be completely and 
rapidly reversible upon the product removal from 
the skin. Furthermore, the effects should ideally 
be unidirectional, allowing only the ingress of 
specifi c xenobiotics without loss of any endoge-
nous component from the body. The penetration 
enhancer should be cosmetically acceptable, 
odorless, inexpensive, tasteless, and colorless. 
 Despite the wide range of purported penetra-
tion enhancers, there is no chemical combining all 
of the desirable attributes. Some chemical enhanc-
ers are specifi cally designed for this purpose such 
as 1-dodecylazacycloheptan-2-one (laurocapram 
or Azone ® ). Other compounds are more com-
mon constituents of topical formulations such as 
surfactants and solvents. The  relative effi cacies 
of enhancers towards distinct drugs have been 
largely explored and compared [ 25 ]. 
 In vivo testing with penetration enhancers was 
performed safely by some researchers in contrast 
to others who reported severe cell damage in the 
epidermis and even skin necrosis [ 26 ]. Such haz-
ards called for ex vivo predictive bioassays on 
human skin or SC [ 26 ,  27 ]. 
 The two classes of penetration enhancers, 
namely, the solvent type and the lipid fl uidizer 
type, are conveniently combined to reach syner-
gistic effects [ 28 ,  29 ]. In complex formulations, 
each component possibly acts in distinct ways, 
precluding any determination of specifi c interac-
tions. Binary and ternary mixtures were reported 
to be more active than single-penetration enhanc-
ers [ 30 ]. However, the ideal combination activity 
of the chemicals is diffi cult to predict unless a 
more precise knowledge of the involved mecha-
nisms has been deciphered. In sum, there is a 
need for accurate assessments of the SC permea-
bility alterations in order to design safe, reliable, 
and effective formulations [ 31 ]. CXM has shown 
its predictive value in this fi eld. 
23.5  Corneoxenometry 
and Dose–Response Effect 
of Chemical Penetration 
Enhancers 
 A dose–response effect was searched for 
 ethanol and laurocapram using the CXM bioas-
say [ 19 ]. In the same study, other assessments 
were performed using a gel formulation (pro-
pylene carbonate, hydroxypropyl cellulose, 
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 butylhydroxytoluene, ethanol, glycerol) contain-
ing 10 % propylene glycol and a combination 
of three other enhancers, namely, N-acetyl-L- 
cysteine (NAC), urea, and salicylic acid. The three 
latter penetration enhancers were incorporated in 
various proportions with keeping the sum of their 
respective concentrations at the 20 % level. 
 Data from CXM appeared reproducible and 
sensitive enough to disclose signifi cant differ-
ences between formulations [ 19 ]. Both the nature 
and concentration of penetration enhancers gov-
erned the RII values. For each test formulation, 
the interindividual variability was reasonably 
low. Linear dose-effect responses were obtained 
with ethanol in the range 0–100 % and laurocap-
ram in the range 0–5 %. The 10 % propylene 
glycol-based gel exhibited a wide range in RII 
values when supplemented with NAC, urea, and 
salicylic acid. NAC exhibited a moderate effect 
on CXM. RII rose with increasing amounts of 
urea replacing NAC. The RII rise was stronger 
when using salicylic acid instead of urea. The 
combination of salicylic acid and urea proved to 
be more active than salicylic acid alone. 
23.6  Corneoxenometry 
and Organic Solvents 
 The effects of organic solvents were studied in 
many instances [ 32 ,  33 ]. In particular, they were 
compared using CXM [ 16 ]. Series of CSSS were 
immersed for 1, 5, 10, 30, 60, or 120 min in vials 
containing deionized water or an organic solvent 
including chloroform, ethanol, hexane, metha-
nol, chloroform-methanol (2:1, v/v), hexane- 
ethanol (2:3, v/v), and hexane-methanol (2:3, 
v/v). After contact with the selected solvent for 
one of the predetermined duration, CSSS were 
thoroughly rinsed under running tap water for 
20 s, air-dried, and stained for 3 min with tolu-
idine blue-basic fuchsin dyes. 
 The ranking from the least to the most aggres-
sive solvent according to the mean CIM was as 
follows: hexane (40.7), ethanol (26.5), metha-
nol (23.5), hexane-ethanol (23.3), chloroform 
(20.8), chloroform-methanol (15.5), and hexane- 
methanol (7.8) [ 16 ]. CIM values showed that 
the effect of hexane-methanol on SC was sig-
nifi cantly higher ( p < 0.01) than those of any 
other solvent with the exception of chloroform- 
methanol. Chloroform-methanol is well known 
as the most potent extraction mixture for lipids 
in biological samples. However, it did not reach 
the top rank using the CXM bioassay [ 16 ]. Such 
a fi nding further illustrated the fact that organic 
solvents may alter other biological components 
which in turn affect the CXM data. No signifi cant 
difference was yielded between ethanol, metha-
nol, and hexane-ethanol, but each of them was 
signifi cantly ( p < 0.05) more active than hexane. 
The infl uence of exposure time between SC and 
solvents showed some solvent-related differ-
ences. However, all correlation were signifi cant 
( p < 0.01) and best fi tted a logarithmic relation-
ship. It appeared that most of the changes in CIM 
were reached within 10 min for each solvent. 
 Despite interindividual inconsistencies in cor-
neocyte alterations, signifi cant differences were 
reported among solvents using the CXM bioas-
say [ 16 ]. The test organic solvents are recognized 
to extract lipids [ 26 ,  27 ,  34 – 37 ]. In addition, 
alterations in the SC other than pure lipid extrac-
tion are likely [ 27 ]. Large interindividual differ-
ences in CIM were found for any of the solvents 
or mixtures [ 16 ] suggesting the variability in the 
overall lipid extraction by these compounds [ 26 ]. 
The alterations induced in the human SC by sol-
vents at the CXM bioassay were indeed reported 
to be more variable in extent that those induced 
by diluted surfactants as shown at the CSM bio-
assay on normal subjects [ 13 ,  16 ]. 
 Conclusion 
 CSM and its CXM variant appear as relevant 
and predictive bioassays for assessing the 
overall effect of single and combined chemi-
cal xenobiotics. They are cheap, rapid, mini-
mally invasive, and relevant to human skin 
reactivity. In addition, the reproducibility, 
specifi city, and sensibility are quite high. 
These bioassays therefore represent valuable 
screening tests proposed as an alternative to 
animal testing and hazardous human testing. 
 The CSM and CXM bioassays allow to 
assess the infl uence of the contact time between 
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the SC and noxious chemicals. The time range 
between 1 and 120 min appears relevant fol-
lowing available information about the kinetics 
of lipid extraction from human SC. The CSM 
and CXM data are in line with a handful of 
other procedures. However, they do not explore 
the effects of xenobiotics on both the living epi-
dermis and the nature and intensity of infl am-
mation that could result in irritant dermatitis. 
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